Report Detail
Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
- RnM2799104 |
- 23 January, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.
According to this study, over the next five years the Transforming Growth Factor Beta 1 market will register a 11.3% CAGR in terms of revenue, the global market size will reach US$ 1790 million by 2024, from US$ 1050 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transforming Growth Factor Beta 1 business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
This study considers the Transforming Growth Factor Beta 1 value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pirfenidone
Galunisertib
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
IPF
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transforming Growth Factor Beta 1 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Transforming Growth Factor Beta 1 market by identifying its various subsegments.
Focuses on the key global Transforming Growth Factor Beta 1 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transforming Growth Factor Beta 1 with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transforming Growth Factor Beta 1 submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Transforming Growth Factor Beta 1 Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Transforming Growth Factor Beta 1 Consumption 2014-2024
- 2.1.2 Transforming Growth Factor Beta 1 Consumption CAGR by Region
- 2.2 Transforming Growth Factor Beta 1 Segment by Type
- 2.2.1 Pirfenidone
- 2.2.2 Galunisertib
- 2.2.3 Others
- 2.3 Transforming Growth Factor Beta 1 Consumption by Type
- 2.3.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2014-2019)
- 2.4 Transforming Growth Factor Beta 1 Segment by Application
- 2.4.1 IPF
- 2.4.2 Cancer
- 2.4.3 Others
- 2.5 Transforming Growth Factor Beta 1 Consumption by Application
- 2.5.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Transforming Growth Factor Beta 1 Value and Market Share by Application (2014-2019)
- 2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2014-2019)
3 Global Transforming Growth Factor Beta 1 by Players
- 3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Players
- 3.1.1 Global Transforming Growth Factor Beta 1 Sales by Players (2017-2019)
- 3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Players (2017-2019)
- 3.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players
- 3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Players (2017-2019)
- 3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players (2017-2019)
- 3.3 Global Transforming Growth Factor Beta 1 Sale Price by Players
- 3.4 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Transforming Growth Factor Beta 1 by Regions
- 4.1 Transforming Growth Factor Beta 1 by Regions
- 4.1.1 Global Transforming Growth Factor Beta 1 Consumption by Regions
- 4.1.2 Global Transforming Growth Factor Beta 1 Value by Regions
- 4.2 Americas Transforming Growth Factor Beta 1 Consumption Growth
- 4.3 APAC Transforming Growth Factor Beta 1 Consumption Growth
- 4.4 Europe Transforming Growth Factor Beta 1 Consumption Growth
- 4.5 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Growth
5 Americas
- 5.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries
- 5.1.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
- 5.1.2 Americas Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
- 5.2 Americas Transforming Growth Factor Beta 1 Consumption by Type
- 5.3 Americas Transforming Growth Factor Beta 1 Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries
- 6.1.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
- 6.1.2 APAC Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
- 6.2 APAC Transforming Growth Factor Beta 1 Consumption by Type
- 6.3 APAC Transforming Growth Factor Beta 1 Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Transforming Growth Factor Beta 1 by Countries
- 7.1.1 Europe Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
- 7.1.2 Europe Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
- 7.2 Europe Transforming Growth Factor Beta 1 Consumption by Type
- 7.3 Europe Transforming Growth Factor Beta 1 Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Countries
- 8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
- 8.2 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Type
- 8.3 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.2 Transforming Growth Factor Beta 1 Distributors
- 10.3 Transforming Growth Factor Beta 1 Customer
11 Global Transforming Growth Factor Beta 1 Market Forecast
- 11.1 Global Transforming Growth Factor Beta 1 Consumption Forecast (2019-2024)
- 11.2 Global Transforming Growth Factor Beta 1 Forecast by Regions
- 11.2.1 Global Transforming Growth Factor Beta 1 Forecast by Regions (2019-2024)
- 11.2.2 Global Transforming Growth Factor Beta 1 Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Transforming Growth Factor Beta 1 Forecast by Type
- 11.8 Global Transforming Growth Factor Beta 1 Forecast by Application
12 Key Players Analysis
- 12.1 Roche
- 12.1.1 Company Details
- 12.1.2 Transforming Growth Factor Beta 1 Product Offered
- 12.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Roche News
- 12.2 Shionogi Ltd
- 12.2.1 Company Details
- 12.2.2 Transforming Growth Factor Beta 1 Product Offered
- 12.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Shionogi Ltd News
- 12.3 Acceleron Pharma Inc
- 12.3.1 Company Details
- 12.3.2 Transforming Growth Factor Beta 1 Product Offered
- 12.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Acceleron Pharma Inc News
- 12.4 Genzyme Corp
- 12.4.1 Company Details
- 12.4.2 Transforming Growth Factor Beta 1 Product Offered
- 12.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Genzyme Corp News
- 12.5 Isarna Therapeutics GmbH
- 12.5.1 Company Details
- 12.5.2 Transforming Growth Factor Beta 1 Product Offered
- 12.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Isarna Therapeutics GmbH News
- 12.6 Scholar Rock
- 12.6.1 Company Details
- 12.6.2 Transforming Growth Factor Beta 1 Product Offered
- 12.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Scholar Rock News
- 12.7 Sirnaomics Inc
- 12.7.1 Company Details
- 12.7.2 Transforming Growth Factor Beta 1 Product Offered
- 12.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Sirnaomics Inc News
- 12.8 Eli Lilly and Co
- 12.8.1 Company Details
- 12.8.2 Transforming Growth Factor Beta 1 Product Offered
- 12.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Eli Lilly and Co News
- 12.9 Formation Biologics Inc
- 12.9.1 Company Details
- 12.9.2 Transforming Growth Factor Beta 1 Product Offered
- 12.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Formation Biologics Inc News
- 12.10 Novartis AG
- 12.10.1 Company Details
- 12.10.2 Transforming Growth Factor Beta 1 Product Offered
- 12.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Novartis AG News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Transforming Growth Factor Beta 1 . Industry analysis & Market Report on Transforming Growth Factor Beta 1 is a syndicated market report, published as Global Transforming Growth Factor Beta 1 Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Transforming Growth Factor Beta 1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
